Journal info
|
||
Select Journal
Journals
Bratislava Medical Journal Endocrine Regulations General Physiology and Biophysics Neoplasma 2024 Ahead of print 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
Neoplasma Vol.67, No.3, p.644–649, 2020 |
||
Title: Association of interlukine-18 polymorphisms with susceptibility to prostate cancer in Iranian population | ||
Author: M. ABEDINZADEH, M. GHODSIAN, S. A. DASTGHEIB, J. JAFARI-NEDOOSHAN, M. ZARE, N. HEIRANIZADEH, A. RAEE-EZZABADI, H. NEAMATZADEH | ||
Abstract: Interleukin-18 (IL-18) is a multifunctional cytokine that augments interferon-γ production, promotion of the Th1 immune response and acts as an important immunomediator in the development of some cancers. The current study aimed to analyze the association of five most common polymorphisms in IL-18 gene with prostate cancer in Iranian population. We examined a possible association of IL-18 -137G>C, -607C>A, -656G>T, +105A>C and +127C>T polymorphisms with prostate cancer occurrence by PCR-RFLP assay. Odds ratio (OR) and 95% confidence interval (CI) were used to assess the strength of the association between IL-18 polymorphisms and prostate cancer. Statistical analysis revealed that individuals carrying the mutant homozygote genotype of IL-18 -607C>A (OR = 2.251, 95% CI = 1.062-4.768, P = 0.034) and -137G>C (OR = 2.364, 95% CI = 1.121-4.984, P = 0.024) polymorphisms had an increased risk of prostate cancer. However, for IL-18 -656G>T, +105A>C and +127C>T polymorphisms, there were no differential distributions of their genotypes between patients with prostate cancer and healthy subjects. Our results indicated that the IL-18 -137G>C and -607C>A polymorphisms were significantly associated with an increased risk of prostate cancer in Iranian population. Thus, these polymorphisms might be used as a molecular biomarker in the early diagnosis of prostate cancer. |
||
Keywords: prostate cancer, interleukin 18, association, polymorphism, genotype | ||
Published online: 15-May-2020 | ||
Year: 2020, Volume: 67, Issue: 3 | Page From: 644, Page To: 649 | |
doi:10.4149/neo_2020_190616N513 |
||
|
download file |
|